TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Madrigal Pharmaceuticals
Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis

Madrigal Pharmaceuticals presented two-year data on Rezdiffra, demonstrating significant improvements in liver imaging tests and biomarkers for patients with compensated MASH cirrhosis, highlighting potential benefits across different patient populations.

Insights
BMLpL   neutral

Buffett is gradually selling Bank of America stock due to increased valuation and changing interest rate environment, suggesting a pragmatic investment approach


MDGL   positive

Presented promising clinical trial results showing treatment improvements across multiple patient groups, with potential to address an unmet medical need in liver disease treatment